Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Surgical Oncology|May 30, 2025
Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic reviewBrendan Desmond, Lobna Alukaidey, Zexi Allan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 16, 2012
Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagusNicholas J Clemons, David H Wang, Daniel Croagh, et al.
Carcinogenesis|June 30, 2010
Nitric oxide-mediated invasion in Barrett's high-grade dysplasia and adenocarcinomaNicholas J Clemons, Nicholas B Shannon, Lakshi R Abeyratne, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Systematic Evaluation Defines the Limits of Ferroptosis in Cancer TherapyKenji M Fujihara, Azmi Aziz, Behnia Akbari, et al.
Annals of Surgical Oncology|February 19, 2015
Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor XenograftsMatthew Read, David Liu, Cuong P Duong, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancersAmel Saadi, Nicholas B Shannon, Pierre Lao-Sirieix, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 27, 2023
Inhibition of BMP2 and BMP4 Represses Barrett's Esophagus While Enhancing the Regeneration of Squamous Epithelium in Preclinical ModelsAna C P Correia, Danielle Straub, Matthew Read, et al.
The Journal of Pathology|August 2, 2020
GRB7 is an oncogenic driver and potential therapeutic target in oesophageal adenocarcinomaJovana R Gotovac, David Sh Liu, Michael J Yates, et al.
Gut|July 19, 2015
APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinomaDavid S H Liu, Matthew Read, Carleen Cullinane, et al.
Cellular and Molecular Gastroenterology and Hepatology|March 28, 2021
Loss of SMAD4 Is Sufficient to Promote Tumorigenesis in a Model of Dysplastic Barrett's EsophagusJovana R Gotovac, Tanjina Kader, Julia V Milne, et al.
Pageof 6